The Sodium/Iodide Symporter (NIS): Molecular Physiology and Preclinical and Clinical Applications

被引:182
|
作者
Ravera, Silvia [1 ]
Reyna-Neyra, Andrea [1 ]
Ferrandino, Giuseppe [1 ]
Amzel, L. Mario [2 ]
Carrasco, Nancy [1 ]
机构
[1] Yale Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06510 USA
[2] Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA
来源
ANNUAL REVIEW OF PHYSIOLOGY, VOL 79 | 2017年 / 79卷
关键词
sodium/iodide symporter; thyroid hormones; NIS mutations; structure/function; gene transfer studies; imaging and radioiodide therapy; SODIUM-IODIDE SYMPORTER; ONCOLYTIC VACCINIA VIRUS; THYROID NA+/I-SYMPORTER; ADENOVIRUS-MEDIATED EXPRESSION; EPIDERMAL-GROWTH-FACTOR; PENDRED-SYNDROME GENE; BREAST-CANCER; IN-VIVO; TRANSPORT-DEFECT; MEASLES-VIRUS;
D O I
10.1146/annurev-physiol-022516-034125
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Active iodide (I-) transport in both the thyroid and some extrathyroidal tissues is mediated by the Na+/I- symporter (NIS). In the thyroid, NIS-mediated I- uptake plays a pivotal role in thyroid hormone (TH) biosynthesis. THs are key during embryonic and postembryonic development and critical for cell metabolism at all stages of life. The molecular characterization of NIS in 1996 and the use of radioactive I- isotopes have led to significant advances in the diagnosis and treatment of thyroid cancer and provide the molecular basis for studies aimed at extending the use of radioiodide treatment in extrathyroidal malignancies. This review focuses on the most recent findings on I- homeostasis and I- transport deficiency-causing NIS mutations, as well as current knowledge of the structure/function properties of NIS and NIS regulatory mechanisms. We also discuss employing NIS as a reporter gene using viral vectors and stem cells in imaging, diagnostic, and therapeutic procedures.
引用
收藏
页码:261 / 289
页数:29
相关论文
共 50 条
  • [41] Genetically targeted radiotherapy of head and neck squamous cell carcinoma using the sodium-iodide symporter (NIS)
    Gaut, AW
    Niu, G
    Krager, KJ
    Graham, MM
    Trask, DK
    Domann, FE
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2004, 26 (03): : 265 - 271
  • [42] The sodium/iodide symporter NIS is a transcriptional target of the p53-family members in liver cancer cells
    Guerrieri, F.
    Piconese, S.
    Lacoste, C.
    Schinzari, V.
    Testoni, B.
    Valogne, Y.
    Gerbal-Chaloin, S.
    Samuel, D.
    Brechot, C.
    Faivre, J.
    Levrero, M.
    CELL DEATH & DISEASE, 2013, 4 : e807 - e807
  • [43] A nonradioactive iodide uptake assay for sodium iodide symporter function
    Waltz, Fanny
    Pillette, Lucie
    Ambroise, Yves
    ANALYTICAL BIOCHEMISTRY, 2010, 396 (01) : 91 - 95
  • [44] Modulation of Sodium Iodide Symporter in Thyroid Cancer
    Lakshmanan, Aparna
    Scarberry, Daniel
    Shen, Daniel H.
    Jhiang, Sissy M.
    HORMONES & CANCER, 2014, 5 (06): : 363 - 373
  • [45] Radioiodide uptake and sodium iodide symporter expression in breast carcinoma
    Damle, Archana A.
    Narkar, Archana A.
    Badwe, Rajendra A.
    INDIAN JOURNAL OF EXPERIMENTAL BIOLOGY, 2011, 49 (06) : 416 - 422
  • [46] Functional analysis and clinical significance of sodium iodide symporter expression in gastric cancer
    Shiozaki, Atsushi
    Ariyoshi, Yosuke
    Iitaka, Daisuke
    Kosuga, Toshiyuki
    Shimizu, Hiroki
    Kudou, Michihiro
    Konishi, Tomoki
    Shoda, Katsutoshi
    Arita, Tomohiro
    Konishi, Hirotaka
    Komatsu, Shuhei
    Kubota, Takeshi
    Fujiwara, Hitoshi
    Okamoto, Kazuma
    Kishimoto, Mitsuo
    Konishi, Eiichi
    Marunaka, Yoshinori
    Ichikawa, Daisuke
    Otsuji, Eigo
    GASTRIC CANCER, 2019, 22 (03) : 473 - 485
  • [47] A systems biology approach to propose a new mechanism of regulation of repetitive prophylaxis of stable iodide on sodium/iodide symporter (NIS)
    Cohen, David P. A.
    Lebsir, Dalila
    Benderitter, Marc
    Souidi, Maamar
    BIOCHIMIE, 2019, 162 : 208 - 215
  • [48] Efficacy of 99mTc pertechnetate and 131I radioisotope therapy in sodium/iodide symporter (NIS)-expressing neuroendocrine tumors in vivo
    Schipper, Meike L.
    Riese, Christoph G. U.
    Seitz, Stephan
    Weber, Alexander
    Behe, Martin
    Schurrat, Tino
    Schramm, Nils
    Keil, Boris
    Alfke, Heiko
    Behr, Thomas M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 (05) : 638 - 650
  • [49] Systemic tumor-targeted sodium iodide symporter (NIS) gene therapy of hepatocellular carcinoma mediated by B6 peptide polyplexes
    Urnauer, Sarah
    Klutz, Kathrin
    Gruenwald, Geoffrey K.
    Morys, Stephan
    Schwenk, Nathalie
    Zach, Christian
    Gildehaus, Franz-Josef
    Roedl, Wolfgang
    Ogris, Manfred
    Wagner, Ernst
    Spitzweg, Christine
    JOURNAL OF GENE MEDICINE, 2017, 19 (05):
  • [50] Upregulation of sodium iodide symporter (NIS) protein expression by an innate immunity component: Promising potential for targeting radiosensitive retinoblastoma
    Samuel, Jaisy
    Singh, Narinderbir
    Kanwar, Jagat Rakesh
    Krishnakumar, Subramanium
    Kanwar, Rupinder Kaur
    EXPERIMENTAL EYE RESEARCH, 2015, 139 : 108 - 114